IGM Biosciences Inc

NAS:IGMS (USA)   Ordinary Shares
$ 9.22 -0.07 (-0.75%) 10:08 PM EST
At Loss
P/B:
3.37
Market Cap:
$ 544.20M
Enterprise V:
$ 291.36M
Volume:
82.37K
Avg Vol (2M):
257.30K
Also Trade In:
Volume:
82.37K
At Loss
Avg Vol (2M):
257.30K

Business Description

IGM Biosciences Inc
NAICS : 325412 SIC : 2834
ISIN : US4495851085

Share Class Description:

IGMS: Ordinary Shares
Description
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
Name Current Vs Industry Vs History
Cash-To-Debt 7.18
Equity-to-Asset 0.43
Debt-to-Equity 0.25
Debt-to-EBITDA -0.17
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.95
Distress
Grey
Safe
Beneish M-Score -2.92
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 42.81
9-Day RSI 48.39
14-Day RSI 49.11
6-1 Month Momentum % 35.27
12-1 Month Momentum % -31.68

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.98
Quick Ratio 7.98
Cash Ratio 7.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -22.4
Shareholder Yield % -1.12

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -12063.8
Net Margin % -11255.25
FCF Margin % -9243.66
ROE % -106.11
ROA % -53.43
ROIC % -265.17
ROC (Joel Greenblatt) % -340.99
ROCE % -63.3

Financials (Next Earnings Date:2024-08-02 Est.)

IGMS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IGMS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

IGM Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.105
EPS (TTM) ($) -4.28
Beta 1.15
Volatility % 114.86
14-Day RSI 49.11
14-Day ATR ($) 0.883011
20-Day SMA ($) 9.15
12-1 Month Momentum % -31.68
52-Week Range ($) 3.81 - 17.7
Shares Outstanding (Mil) 59.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

IGM Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

IGM Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

IGM Biosciences Inc Frequently Asked Questions

What is IGM Biosciences Inc(IGMS)'s stock price today?
The current price of IGMS is $9.22. The 52 week high of IGMS is $17.70 and 52 week low is $3.81.
When is next earnings date of IGM Biosciences Inc(IGMS)?
The next earnings date of IGM Biosciences Inc(IGMS) is 2024-08-02 Est..
Does IGM Biosciences Inc(IGMS) pay dividends? If so, how much?
IGM Biosciences Inc(IGMS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1